Diverse mechanisms of antiepileptic drugs in the development pipeline

This publication has 138 references indexed in Scilit:

• The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study
  Cerebrovascular Diseases, 2005
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
  Nature Reviews Neuroscience, 2005
• Could Valerian Have Been the First Anticonvulsant?
  Epilepsia, 2004
• Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
  Molecular Pharmacology, 2004
• Comparison of the Pharmacological Properties of Rat NaV1.8 with Rat NaV1.2a and Human NaV1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPRR
  Receptors and Channels, 2004
• Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents
  British Journal of Pharmacology, 2003
• The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine
  Neurochemistry International, 2002
• Interaction of the Novel Anticonvulsant, BIA 2‐093, with Voltage‐Gated Sodium Channels: Comparison with Carbamazepine
  Epilepsia, 2001
• Clinical Pharmacology of Valpromide
  Clinical Pharmacokinetics, 1991
• Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in mice
  Fundamental and Applied Toxicology, 1986